Amine metabolites in ventricular cerebrospinal fluid in coma

Area of Science:

• Neurochemistry
• Neurology
• Critical Care Medicine

Background:

• Coma following acute brain injury, tumors, or cerebrovascular accidents presents significant diagnostic and prognostic challenges.
• Cerebrospinal fluid (CSF) contains neurotransmitter metabolites that may reflect brain metabolic state.
• Understanding these metabolites could offer insights into coma pathophysiology and patient outcomes.

Purpose of the Study:

• To measure concentrations of key neurotransmitter metabolites in the CSF of comatose patients.
• To investigate the relationship between these metabolite levels and clinical outcomes, including recovery and mortality.
• To explore potential correlations between metabolite levels and intracranial pressure.

Main Methods:

• Ventricular CSF samples were collected from 15 comatose patients.
• Concentrations of homovanillic acid (HVA), 3-methoxy, 4-hydroxyphenylglycol (MHPG), and 5-hydroxyindolylacetic acid (5-HIAA) were quantified.
• Metabolite levels were analyzed in relation to ventricular fluid pressure, patient recovery, and survival status.

Main Results:

• No significant correlation was found between metabolite levels and ventricular fluid pressure.
• In patients who recovered, CSF metabolite levels remained largely stable, with two exceptions showing increased HVA during coma progression.
• Significantly higher MHPG concentrations were observed in patients who died compared to those who recovered (P < 0.02).

Conclusions:

• MHPG levels in CSF may serve as a potential biomarker for predicting mortality in comatose patients.
• HVA and 5-HIAA levels do not appear to be strong indicators of outcome in this patient cohort.
• Further research is warranted to elucidate the role of MHPG in the neurobiology of coma and its prognostic value.